Senior insider sale
Chief Financial Officer at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$94.5K
2.55K shares
What this filing means
AULIN SHERRY plans to sell 2.55K shares of XENON PHARMACEUTICALS INC. valued at approximately $94.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/19/2025ACC: 0001193125-25-209529
Officer· Chief Financial Officer
Since Jun 2021
2.55K
Shares to sell
$94.5K
Approx. market value
9.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Options
Net exercise
9/19/2025
9.17KTotal acquired9.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2025 | Exercise of Options Net exercise | 9.17K | — |
| Total | 9.17K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.55K
Market value
$94.5K
9/19/2025
Total
Units
2.55K
Value
$94.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/19/2025 | 2.55K | $94.5K | NASDAQ | Planned |
| Total | 2.55K | $94.5K | ||